2023Open access34cites
Diosmin nanocrystal gel alleviates imiquimod-induced psoriasis in rats via modulating TLR7,8/NF-κB/micro RNA-31, AKT/mTOR/P70S6K milieu, and Tregs/Th17 balanceInflammopharmacology, Psoriasis: Treatment and Pathogenesis
Active, last published 2026
0
H-index
0
Citations
Yasmine has not officially claimed their profile. If you are Yasmine, claim it free.
Claim Your Profile01 · About the work
What I study
research summary for Yasmine Shahine will appear here once their profile is updated.
02 · Reach
Publication output and reach
Yasmine's work has been cited 0 times across 4 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
06 · Where I am
Affiliations
CurrentlyPharos University in Alexandria, Egypt
Research themes (UN SDGs)
07 · Selected work
Recent publications
2024Open access14cites
A drug repurposing approach of Atorvastatin calcium for its antiproliferative activity for effective treatment of breast cancer: In vitro and in vivo assessmentInternational Journal of Pharmaceutics X, Cancer, Lipids, and Metabolism
2024Open access3cites
Anti-IL-8 monoclonal antibodies inhibits the autophagic activity and cancer stem cells maintenance within breast cancer tumor microenvironment1Breast Disease, Autophagy in Disease and Therapy
2024Open access
The Antiangiogenic Activity of Anti-IL-6 and Anti-IL-8 in the Tumor Microenvironment of Breast Cancer (Preclinical Study)Journal of Advanced Pharmaceutical Sciences, Angiogenesis and VEGF in Cancer
2025Open access2cites
Novel Luteolin-Zein Nanocomposite Incorporated in Hyaluronic Acid/Sodium Alginate Scaffold as Potential Immunomodulation for Pressure Ulcer WoundsAAPS PharmSciTech, Wound Healing and Treatments
Are you Yasmine?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
No commitment required